Llinàs-Arias, P.; Íñiguez-Muñoz, S.; McCann, K.; Voorwerk, L.; Orozco, J.I.J.; Ensenyat-Mendez, M.; Sesé, B.; DiNome, M.L.; Marzese, D.M.
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers 2021, 13, 4139.
https://doi.org/10.3390/cancers13164139
AMA Style
Llinàs-Arias P, Íñiguez-Muñoz S, McCann K, Voorwerk L, Orozco JIJ, Ensenyat-Mendez M, Sesé B, DiNome ML, Marzese DM.
Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers. 2021; 13(16):4139.
https://doi.org/10.3390/cancers13164139
Chicago/Turabian Style
Llinàs-Arias, Pere, Sandra Íñiguez-Muñoz, Kelly McCann, Leonie Voorwerk, Javier I. J. Orozco, Miquel Ensenyat-Mendez, Borja Sesé, Maggie L. DiNome, and Diego M. Marzese.
2021. "Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer" Cancers 13, no. 16: 4139.
https://doi.org/10.3390/cancers13164139
APA Style
Llinàs-Arias, P., Íñiguez-Muñoz, S., McCann, K., Voorwerk, L., Orozco, J. I. J., Ensenyat-Mendez, M., Sesé, B., DiNome, M. L., & Marzese, D. M.
(2021). Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer. Cancers, 13(16), 4139.
https://doi.org/10.3390/cancers13164139